Results 71 to 80 of about 8,977,908 (300)
Clinical evidence, 2002 Meningococcal disease occurs as both endemic and epidemic disease in most parts of the world with significant morbidity and mortality. Among the different serogroups of Neisseria meningitidis, serogroups A, B, C account for 90% of the disease. In the last few years there has been a change in the epidemiology of the disease with an increase in the ...
J, Correia, C A, Hart
openaire +7 more sources
Brazilian Journal of Infectious Diseases, 2014 Objectives: To analyze the behavior of meningococcal disease in the Federal District, Brazil, from 2005 to 2011, and to assess the direct impact of the meningococcal serogroup C conjugate vaccine.
Márcia de Cantuária Tauil +3 more
doaj
The important lessons lurking in the history of meningococcal epidemiology
Expert Review of VaccinesIntroduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use during the ...
Ray Borrow, Jamie Findlow
doaj +1 more source
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
npj Vaccines, 2021 Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical manifestations, but the bacteria share up to 80–90% genome sequence identity.
Yara Ruiz García +9 more
doaj +1 more source
Escherichia coli in the production of biopharmaceuticals
Biotechnology and Applied Biochemistry, Volume 72, Issue 2, Page 528-541, April 2025.Abstract Escherichia coli has shouldered a massive workload with the discovery of recombinant DNA technology. A new era began in the biopharmaceutical industry with the production of insulin, the first recombinant protein, in E. coli and its use in treating diabetes. After insulin, many biopharmaceuticals produced from E. coli have been approved by the
İbrahim İncir, Özlem Kaplan
wiley +1 more source
International Journal of Environmental Research and Public Health, 2018 The aims of this study were (i) to evaluate the relationship between official data on invasive meningococcal disease cases in Sardinia and the reporting of the cases by a regional online newspaper and (ii) to identify indicators useful for understanding ...
M. Dettori +8 more
semanticscholar +1 more source
Infectious Diseases and Therapy, 2019 Neisseria meningitidis is a major cause of meningitis and septicemia with cases, outbreaks, and epidemics reported globally in industrialized and non-industrialized countries. N. meningitidis is categorized into 12 serogroups; however, only 5 serogroups (
Jessica Presa +4 more
doaj +1 more source
Mixture of Input-Output Hidden Markov Models for Heterogeneous Disease Progression Modeling [PDF]
arXiv, 2022 A particular challenge for disease progression modeling is the heterogeneity of a disease and its manifestations in the patients. Existing approaches often assume the presence of a single disease progression characteristics which is unlikely for neurodegenerative disorders such as Parkinson's disease.
arxiv
Clinical Case Reports, Volume 13, Issue 4, April 2025.ABSTRACT Meningococcal meningitis can lead to serious neurological complications such as hydrocephalus directly and contribute to cerebral small vessel disease indirectly, especially in patients with pre‐existing conditions like dilated cardiomyopathy.
Yousif Mohamed +3 more
wiley +1 more source
Meningococcal Disease Surveillance in Men Who Have Sex with Men — United States, 2015–2016
MMWR. Morbidity and mortality weekly report, 2018 Meningococcal disease is a rare, but serious, bacterial infection that progresses rapidly and can be life-threatening, even with prompt antibiotic treatment.
C. Bozio +12 more
semanticscholar +1 more source